Financial Toxicity In Cancer Patients Receiving Immunotherapy Drugs

Researched by Belong.Life and published by ESMO, 2020 Authors: D Vorobiof, L Hasid, A Litvin, I Deutsch, E Malki. FT has been described as the harmful personal financial burden faced by all patients receiving cancer treatments. Physicians should not be waiting for behavioural changes such as poor compliance, or low or nonadherence, caused by financial […]

Financial Toxicity in American Patients Receiving Cancer Immunotherapy Drugs

Researched by Belong.Life and published by ASCO, 2020Authors: Daniel A. Vorobiof, Lior Hasid, Alon Litvin, Irad Deutsch, Eliran Malki Background: Real-word data obtained through cutting edge technology paired with consumer mobile devices on 310 worldwide pts, members of Belong.life, an international mobile application, who received immunotherapy for diverse solid tumors, was obtained following a short, […]

Covid 19 infection leading to a subsequent new primary cancer diagnosis, Real-world data (RWD) analysis on members of Belong.life, a global cancer application

Researched by Belong.Life and published by ASCO Authors: Daniel A. Vorobiof, Bozhena Haikin, Alon Litvin, Irad Deutsch, Eliran Malki. Background:Some known viral infections can lead to a diagnosis of cancer (e.g: HPV, HIV, EBV, etc.) Anecdotical reports of a Covid 19 infection, and the subsequent diagnosis of a new cancer have been mentioned by few […]

The prevalence of Cannabis-related arrhythmias – Real world data evidence (RWDE) and patient’s reported outcomes (PRO) by using BELONG.life digital application (app).

Avishag Laish-Farkash, MD PhD, Luba Vasilenko, MD, Noy Moisa, BSc, Daniel Vorobiof, MD Cannabis consumption has been shown to cause arrhythmias with various ambiguous combinations, including ventricular tachycardia, and potentially sudden death. Suspected mechanisms are: effects of marijuana on cardiac ion channels and on the central nervous system. We aimed to investigate the RWDE and […]

Identifying The Patient Journey And Treatment Lines Patterns In Metastatic Pancreatic Cancer​

Researched by Belong.Life and published by ASCO, 2018 Authors: Daniel Vorobiof, Irad Deutsch, Eliran Malki, Maytal Bivas-Benita Introduction: Checkpoint inhibitors such as programmed cell death receptor 1 (PD-1) antibodies have significantly improved the prognosis in several malignancies. While treatment with the PD-1 targeting antibodies, pembrolizumab and nivolumab, has substantial clinical benefit, it is associated with […]

Mapping PD-1 Inhibitors’ Side Effects Using Patient Reported Outcomes

Researched by Belong.Life and published by ASCOData from the Belong PPN successfully captured the spectrum of PD-1 inhibitors’ reported AEs. Analyzing PRO of post approval treatments could provide deeper understanding of treatment patterns, expose limiting AE that bear implications on cost of treatment, indicate patients’ quality of life (QOL), improve management recommendations and provide a […]

Unveiling The Real-World Outcomes Of Breast Cancer Patients With Taxanes-Induced Neuropathy Using A Digital Patient-Powered Network

Researched by Belong.Life and published by ASCO, 2019 Authors: Raanan Berger, Lior Hasid, Irad Deutsch, Eliran Malki, Maytal Bivas-Benita Background: Taxanes-induced neuropathy is common in BC patients receiving taxanes, forcing dose reductions and treatment delays and posing serious challenges for the long-term patient QoL. Discovering neuropathy predictors in patients could guide better treatment decisions, improved […]

Creating The Real-World Medical Record: Using Digital Patient-Generated Data To Create An Updated Picture Of Patients Outcomes

Researched by Belong.Life and published by ASCO, 2019 Authors: Maytal Bivas-Benita , Irad Deutsch, Eliran Malki, Lior Hasid Background: Value-based healthcare requires integration of real-world data (RWD) generated by patients in parallel to clinical documentation. This gives a holistic perspective of the patients’ health and care and could lead to reduced costs and better patient […]

Patients Reported Outcomes In Breast Cancer: Physical, Emotional Side Effects, Financial Toxicity, And Complementary Usage Relations

Researched by Belong.Life and published by ASCO, 2019 Authors: Daniel A. Vorobiof, Eliran Malki, Irad Deutsch, Lior Hasid Background: RWD denotes data accumulated via electronic health records as well as cutting edge technology paired with consumer mobile devices. Artificial intelligence (AI) incorporates the use of algorithms and machine learning (ML) software to analyze complex medical […]